People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Renovaro Inc. | — | Other Health Care | Series D+ | $123.3M | $1.2B | 2024 |
Mark Dybul at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Dybul on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Sapirstein | 1 | 7 |
| Carol Brosgart | 1 | 3 |
| Gregg Alton | 1 | 2 |
| AVRAM MILLER | 1 | 2 |
| Leni Boeren | 1 | 1 |
| Karen Brink | 1 | 1 |
| Luisa Puche | 1 | 1 |
| Jayne McNicol | 1 | 1 |
| Ruud Hendriks | 1 | 1 |
| Rene Sindlev | 1 | 1 |
| Francois Binette | 1 | 1 |
| Eric Leire | 1 | 1 |
| N. E. Nielsen | 1 | 1 |
| Aldo Michael Noes Petersen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.